Description of a bivalent cannabinoid ligand with hypophagic properties

Arch Pharm (Weinheim). 2013 Mar;346(3):171-9. doi: 10.1002/ardp.201200392. Epub 2013 Feb 1.

Abstract

A series of bivalent cannabinoid ligands is proposed. The synthesis of double amides based on the rimonabant structure separated by an alkyl chain and the evaluation of their affinities for cannabinoid receptors are reported. The data of 4d confirmed that a bivalent structure is a suitable scaffold for CB1 cannabinoid receptor binding. The compound 4d was selected for in vitro and in vivo pharmacological evaluations. Moreover, intraperitoneal administration of 4d to food-deprived rats resulted in a dose-dependent inhibition of feeding that was maintained up to 240 min.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cannabinoid Receptor Antagonists / chemical synthesis*
  • Cannabinoid Receptor Antagonists / chemistry
  • Cannabinoid Receptor Antagonists / pharmacology
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Drug Design*
  • Feeding Behavior / drug effects*
  • Food Deprivation
  • Humans
  • Ligands
  • Male
  • Mice
  • Mice, Inbred ICR
  • Molecular Structure
  • Piperidines / chemical synthesis*
  • Piperidines / chemistry
  • Piperidines / pharmacology
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / metabolism
  • Prefrontal Cortex / pathology
  • Protein Binding
  • Pyrazoles / chemical synthesis*
  • Pyrazoles / chemistry
  • Pyrazoles / pharmacology
  • Radioligand Assay
  • Receptor, Cannabinoid, CB1 / genetics
  • Receptor, Cannabinoid, CB1 / metabolism*
  • Rimonabant
  • Structure-Activity Relationship
  • Transfection

Substances

  • Cannabinoid Receptor Antagonists
  • Ligands
  • Piperidines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • Rimonabant